Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization

被引:44
作者
Moseson, Dana E. [1 ]
Corum, Isaac D. [1 ]
Lust, Andres [1 ]
Altman, Kevin J. [1 ]
Hiew, Tze Ning [1 ]
Eren, Ayse [2 ]
Nagy, Zoltan K. [2 ]
Taylor, Lynne S. [1 ]
机构
[1] Purdue Univ, Coll Pharm, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA
[2] Purdue Univ, Coll Engn, Charles B Davidson Sch Chem Engn, W Lafayette, IN 47907 USA
基金
美国国家科学基金会;
关键词
amorphous solid dispersion; crystallinity; dissolution; hot melt extrusion; matrix crystallization; LIQUID PHASE-SEPARATION; IN-VIVO PERFORMANCE; SUPERSATURATED SOLUTIONS; GROWTH-RATE; SOLUBILITY ADVANTAGE; DRUG CRYSTALLINITY; SIZE DISTRIBUTION; BEHAVIOR; IMPACT; VITRO;
D O I
10.1208/s12248-021-00598-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Crystallinity in an amorphous solid dispersion (ASD) may negatively impact dissolution performance by causing lost solubility advantage and/or seeding crystal growth leading to desupersaturation. The goal of the study was to evaluate underlying dissolution and crystallization mechanisms resulting from residual crystallinity contained within bicalutamide (BCL)/polyvinylpyrrolidone vinyl acetate copolymer (PVPVA) ASDs produced by hot melt extrusion (HME). In-line Raman spectroscopy, polarized light microscopy, and scanning electron microscopy were used to characterize crystallization kinetics and mechanisms. The fully amorphous ASD (0% crystallinity) did not dissolve completely, and underwent crystallization to the metastable polymorph (form 2), initiating in the amorphous matrix at the interface of the amorphous solid with water. Under non-sink conditions, higher extents of supersaturation were achieved because dissolution initially proceeded unhindered prior to nucleation. ASDs containing residual crystallinity had markedly reduced supersaturation. Solid-mediated crystallization (matrix crystallization) consumed the amorphous solid, growing the stable polymorph (form 1). Under sink conditions, both the fully amorphous ASD and crystalline physical mixture achieve faster release than the ASDs containing residual crystallinity. In the latter systems, matrix crystallization leads to highly agglomerated crystals with high relative surface area. Solution-mediated crystallization was not a significant driver of concentration loss, due to slow crystal growth from solution in the presence of PVPVA. The high risk stemming from residual crystallinity in BCL/PVPVA ASDs stems from (1) fast matrix crystallization propagating from crystal seeds, and (2) growth of the stable crystal form. This study has implications for dissolution performance outcomes of ASDs containing residual crystallinity.
引用
收藏
页数:18
相关论文
共 80 条
[1]   Evaluation of the Effect of Seed Preparation Method on the Product Crystal Size Distribution for Batch Cooling Crystallization Processes [J].
Aamir, E. ;
Nagy, Z. K. ;
Rielly, C. D. .
CRYSTAL GROWTH & DESIGN, 2010, 10 (11) :4728-4740
[2]   The Impact of Direct Nucleation Control on Crystal Size Distribution in Pharmaceutical Crystallization Processes [J].
Abu Bakar, Mohd R. ;
Nagy, Zoltan K. ;
Saleemi, Ali N. ;
Rielly, Chris D. .
CRYSTAL GROWTH & DESIGN, 2009, 9 (03) :1378-1384
[3]   Assessment of the Amorphous "Solubility" of a Group of Diverse Drugs Using New Experimental and Theoretical Approaches [J].
Almeida e Sousa, Luis ;
Reutzel-Edens, Susan M. ;
Stephenson, Gregory A. ;
Taylor, Lynne S. .
MOLECULAR PHARMACEUTICS, 2015, 12 (02) :484-495
[4]   Characterizing the Impact of Hydroxypropylmethyl Cellulose on the Growth and Nucleation Kinetics of Felodipine from Supersaturated Solutions [J].
Alonzo, David E. ;
Raina, Shweta ;
Zhou, Deliang ;
Gao, Yi ;
Zhang, Geoff G. Z. ;
Taylor, Lynne S. .
CRYSTAL GROWTH & DESIGN, 2012, 12 (03) :1538-1547
[5]   Dissolution and Precipitation Behavior of Amorphous Solid Dispersions [J].
Alonzo, David E. ;
Gao, Yi ;
Zhou, Deliang ;
Mo, Huaping ;
Zhang, Geoff G. Z. ;
Taylor, Lynne S. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (08) :3316-3331
[6]   Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution [J].
Alonzo, David E. ;
Zhang, Geoff G. Z. ;
Zhou, Deliang ;
Gao, Yi ;
Taylor, Lynne S. .
PHARMACEUTICAL RESEARCH, 2010, 27 (04) :608-618
[7]   Physicochemical Characterization of Hot Melt Extruded Bicalutamide-Polyvinylpyrrolidone Solid Dispersions [J].
Andrews, Gavin P. ;
Abudiak, Osama A. ;
Ones, David S. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (03) :1322-1335
[8]   Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs [J].
Baghel, Shrawan ;
Cathcart, Helen ;
O'Reilly, Niall J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (09) :2527-2544
[9]   Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state [J].
Bhugra, Chandan ;
Pikal, Michael J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (04) :1329-1349
[10]  
Butreddy A., 2020, EUR J PHARM SCI